Hillstream BioPharma, Inc.
HILS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,559 | $10,935 | $6,511 | $4 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $162 | $11 | $178 | $617 |
| Total Curr. Assets | $3,722 | $10,946 | $6,689 | $622 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,722 | $10,946 | $6,689 | $622 |
| Liabilities | – | – | – | – |
| Payables | $1,090 | $909 | $955 | $1,463 |
| Short-Term Debt | $0 | $0 | $0 | $1,393 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $698 |
| Other Curr. Liab. | $1,324 | $906 | $190 | $1,678 |
| Total Curr. Liab. | $2,414 | $1,815 | $1,145 | $4,534 |
| LT Debt | $0 | $0 | $0 | $773 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $955 | $773 |
| Other Liabilities | $0 | $0 | -$955 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,414 | $1,815 | $1,145 | $5,307 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $1 | $1 | $1 |
| Retained Earnings | -$36,901 | -$24,704 | -$15,384 | -$6,911 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $38,209 | $33,834 | $20,927 | $2,226 |
| Total Equity | $1,308 | $9,131 | $5,544 | -$4,685 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,722 | $10,946 | $6,689 | $622 |
| Net Debt | -$3,559 | -$10,935 | -$6,511 | $2,161 |